Yingwei Xue
机构：Harbin Medical University, Third Affiliated Hospital of Harbin Medical University · ORCID：0000-0002-8427-9736
发表论文 174 篇 · 总被引 4519 次 · h-index 34
代表论文
- Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial (2025 · The Lancet Oncology · 被引 56)
- Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial (2024 · Journal of Hematology & Oncology · 被引 36)
- Integrating Machine Learning and the SHapley Additive exPlanations (SHAP) Framework to Predict Lymph Node Metastasis in Gastric Cancer Patients Based on Inflammation Indices and Peripheral Lymphocyte Subpopulations (2024 · Journal of Inflammation Research · 被引 28)
- Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor (2024 · World Journal of Gastroenterology · 被引 16)
- Body composition change indices combined with Prognostic Nutritional Index predicts the clinical outcomes of patients with gastric cancer treated with immune checkpoint inhibitor (2024 · Cancer Medicine · 被引 15)
- Normalization weighted combination scores re-evaluate TNM staging of gastric cancer: a retrospective cohort study based on a multicenter database (2023 · International Journal of Surgery · 被引 10)